Base de datos - (CIANE) | |
Presentación de esta base de datos documental (Sitio web de CIANE) |
https://ciane.net/id=2795 | ➡ Editar este registro |
Ficha bibliográfica (sin autores) : | Comparison of vaginal and oral doses of misoprostol for labour induction in post-term pregnancies - Journal of Clinical and Diagnostic Research - Vol. 10, 3 - p.QC09-QC11 |
Autores : | Rezaie, M.; Farhadifar, F.; Mohammadi, S.M.; Nayebi, M. |
Año de publicación : | 2016 |
URL(s) : | https://www.scopus.com/inward/record.uri?eid=2-s2.… |
Résumé (français) : |
|
Abstract (English) : | Introduction: Considering maternal complications, it is preferred to induce labour after 40 weeks. Labour induction is a procedure used to stimulate uterine contractions during pregnancy before the beginning of the labour. Aim: The aim of this study was to compare oral misoprostol with vaginal misoprostol for induction of labour in post-term pregnancies. Materials and Methods: This double blind clinical-trial study was performed on 180 post-term pregnant women who were admitted to the labour ward of Besat Hospital Sanandaj, Iran in 2013-2014. Participants were equally divided into three groups using block randomization method. The induction was performed for the first group with 100 μg of oral misoprostol, for the second group with 50 μg of oral misoprostol, and for the third group with 25 μg of vaginal misoprostol. Vaginal examination and FHR was done before repeating each dose to determine Bishop Score. Induction time with misoprostol to the start of uterine contractions, induction time to delivery, and mode of delivery, systolic tachycardia, hyper stimulation and fetal outcomes were studied as well. Results: First minute Apgar scores and medication dosage of the study groups were significantly different (p=0.0001). But labour induction, induction frequency, mode of delivery, complications, and 5 minutes Apgar score in the groups had no significant difference (p>0.05). The risk of fetal distress and neonatal hospitalization of the groups were statistically significant (p=0. 02). There was no significant difference between the three groups in terms of mean time interval from the administration of misoprostol to the start of uterine contractions (labour induction), the time interval from the start of uterine contractions to delivery and taking misoprostol to delivery. From the administration of misoprostol to start of the uterine contractions the mean difference between time intervals in the three groups were not statistically significant. Conclusion: Based on our findings it can be concluded that prescribing 100μg oral misoprostol is effective than 50 μg oral or 25 μg vaginal misoprostol in terms of induction time, maternal and neonatal outcomes in post- term pregnancy. However, the best dose and route should be decided according to evidence based information. ©2016, Journal of Clinical and Diagnostic Research. All Rights Reserved. |
Sumário (português) : |
|
Resumen (español) : | |
Comentarios : | |
Argument (français) : |
|
Argument (English): |
|
Argumento (português): |
|
Argumento (español): | |
Palabras claves : | |
Autor de este registro : | Import 26/11/2017 — 26 Nov 2017 |
Debate (mostrar sólo español) | ||
---|---|---|
[Ocultar la póliza] ➡ Carta de debate 1) Los comentarios pretenden aclarar el contenido del artículo o proporcionar enlaces a información adicional sobre el tema 2) Los comentarios son públicos y las opiniones expresadas son responsabilidad exclusiva del autor 3) Evite cualquier anécdota o relato personal 4) Los comentarios que se salgan del tema o contengan un lenguaje inaceptable serán eliminados sin previo aviso |
Realizar otra consulta de expertos --- Realice otra consulta sencilla
Creación de un registro --- Importación de registros
Gestión de usuarios --- Salvaguardar la base de datos --- Contacto
Esta base de datos creada por la Alliance francophone pour l'accouchement respecté (AFAR) está gestionada
por el Collectif interassociatif autour de la naissance (CIANE, https://ciane.net).
Se nutre de las contribuciones de voluntarios interesados en compartir información científica.
Si está de acuerdo con este proyecto, puede ayudarnos de varias maneras:
(1) convertirse en colaborador de esta base de datos, si tiene alguna experiencia en documentación
(2) ou apoio financeiro CIANE (veja abaixo)
(3) o hacerse miembro de otra asociación afiliada al CIANE.
➡ Inicie sesión o cree una cuenta para seguir los cambios o convertirse en editor.
➡ Contacta con bibli(arobase)ciane.net para más información.
Donar a CIANE (haga clic en 'Faire un don') nos ayudará a mantener y desarrollar sitios y bases de datos públicas para apoyar las decisiones informadas de los progenitores y profesionales de la salud con respecto al parto |